Preview: Camp4 Therapeutics Corporation Set To IPO Tomorrow
Preview: Camp4 Therapeutics Corporation Set To IPO Tomorrow
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.CAMP4 Therapeutics Corporation (NASDAQ:CAMP) IPO will take place October, 11 on the NASDAQ exchange under the ticker CAMP.
CAMP4 Therapeutics 公司 (納斯達克代碼：CAMP) 的首次公開募股將於10月11日在納斯達克交易所進行，股票代碼爲 CAMP。
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on April 09, 2025.
該公司正在以每股14.00美元至16.00美元的預期價格提供股份，內部限售期爲180天，截至2025年4月09日。
See also: Benzinga IPO Calendar
參見：Benzinga IPO日曆
About CAMP4 Therapeutics Corporation
關於 CAMP4 Therapeutics 公司
CAMP4 Therapeutics Corporation is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics with the goal of upregulating gene expression and restoring healthy protein levels to treat a broad range of genetic diseases.
CAMP4 Therapeutics 公司是一家臨床階段生物製藥公司，開拓性地發現和開發基於調節 RNA 的治療藥物，旨在上調基因表達並恢復健康蛋白水平，以治療廣泛的遺傳性疾病。
See also: Benzinga's Most Shorted Stocks
參見：Benzinga的做空集合股
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成並由編輯審查。
